Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors

Cancer Research

Volumn 56, Issue 23, 1996, Pages 5499-5505

  Voorzanger, Nathalie ^a   Touitou, Robert ^b   Garcia, Eric ^c   Delecluse, Henry Jacques ^d   Rousset, Françoise ^c   Joab, Irène ^b   Favrot, Marie C ^a   Blay, Jean Yves ^a  

^a CENTRE LÉON BÉRARD   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c MERCK RESEARCH LABORATORIES   (United States)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

B-LYMPHOCYTES; CELL DIVISION; DRUG SYNERGISM; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-6; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030447760     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Fiorentino, D. F , Bond, M. W., and Mosmann, T. R. Two types of mouse T helper cell. IV Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 170. 2081-2095, 1989.
2. Fiorentino, D F , Zlotnik, A, Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., and O'Garra, A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146: 3444-3451, 1991.
3. O'Garra, A., Stapleton, G , Dhar, V., Pearce, M., Schumacher, J., Rugo, H., Barbis, D., Stall, A., Cupp, J., Moore, K., Vieira, P., Mosmann, T., Whitmore, A , Arnold, L , Haughton, G., and Howard, M. Production of cytokines by mouse B cell. B lymphomas and normal B cells produce interleukin 10. Int. Immunol., 2: 821-832, 1990.
4. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G , and de Vries, J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 174: 1209-1220, 1991.
5. Rousset, F , Garcia, E , Defrance, T., Peronne, C., Vezzio, N., Hsu, D H., Kastelein, R., Moore, K W., and Banchereau, J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Immunology, 89: 1890-1893, 1992
6. Miyazaki, I , Cheung, R K , and Dosch, H M. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp. Med., 178: 439-447, 1993
7. de Waal Malefyt, R , Haanen, J , Spits, H , Roncarolo, M. G , Velde, A T., Figdor, C , Johnson, K , Kastelein, R., Yssel, H., and de Vries, J E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174: 915-924, 1991
8. Ralph, P., Nakoinz, I , Sampson-Johannes, A , Fong, S , Lowe, D , Min, H. Y , and Lin, L IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor J. Immunol., 148: 808-814, 1992.
9. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R , Howard, M , and O'Garra, A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol., 147: 3815-3822, 1991
10. Taga, K., and Tosato, G IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol., 148: 1143-1148, 1992.
11. Del Pret, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., and Romagnani, S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol., 150: 353-360, 1993.
12. Emilie, D, Touitou, R., Raphael, M., Peuchmaur, M., Devergne, O., Rea, D., Coumbaras, J , Crevon, M. C., Edelman, L., Joab, I , and Galanaud, P. In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol., 22: 2937-2942, 1992.
13. Blay, J. Y., Burdin, N., Rousset, F., Lenoir, G., Biron, P., Philip, T., Banchereau, J., and Favrot, M C Serum IL-10 in non-Hodgkin's lymphoma, a prognostic factor Blood, 82 2169-2174, 1993.
14. Stasi, R., Zinzani, P. L., Galieni, P., Lauta, V M , Damasio, E , Dispensa, E , Dammacco, F , Papa, G , and Tura, S. Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non Hodgkin's lymphoma Br J. Hematol , 88. 770-777, 1994
15. Stasi, R., Zinzani, P L , Galieni, P., Lauta, V. M , Damasio, E., Dispensa, E , Dammacco, F , Papa, G., and Tura, S Detection of soluble interleukin-2 receptor and interleukin 10 in the serum of patients with aggressive non Hodgkin's lymphoma. Cancer (Phila), 74. 1792-1800, 1994.
16. Ludwig, H , Nachbaur, D M , Fritz, E , Krainer, M., and Huber, H Interleukin-6 is a prognostic factor in multiple myeloma. Blood, 77: 2794-2795, 1991
17. Blay, J. Y., Negrier, S , Combaret, V., Attali, S , Goillot, E., Merrouche, Y., Mercatello, A , Ravault, A , Tourani, J. M., Moskovtchenko, J F , Philip, T., and Favrot, M. Serum level of interleukin 6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res , 52: 3317-3322, 1992.
18. Scala, G., Quinto, I , Ruocco, M R Arcucci, A., Mallardo, M., Caretto, P., Forni, G , and Venuta, S. Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity J. Exp. Med., 172 61-68, 1990
19. Yee, C., Biondi, A , Wang, X. H , Iscove, N. N., De Sousa, J , Aarden, L. A., Wong, G G , Clark, S. C., Messner, H A., and Minden, M D. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood, 74: 798-804, 1989.
20. Emilie, D., Cournbaras, J., Raphael, M , Devergne, O., Delecluse, H. J., Gisselbrecht, C., Michiels, J. F., Van Damme, J., Taga, T., Kishimoto, T., Crevon, M. C., and Galanaud, P Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficency syndrome and in human immunodeficiency virus-seronegative patients. Blood, 80: 498-504, 1992
21. Freeman, G L., Freedman, A. S., Rabinowe, S. N., Segil, J. M., Horowitz, J., Rosen, K., Whitman, J. F., and Nadler, L. M Interleukin 6 gene expression in normal and neoplastic B cells. J. Clin. Invest., 83. 1512-1518, 1989
22. Kurzrock, R., Redman, J., Cabanillas, F., Jones, D., Rothberg, J., and Talpaz, M Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res., 53: 2118-2122, 1993.
23. Seymour, J. F , Talpaz, M., Cabanillas, F., Wetzler, M., and Kurzrock, R. Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J Clin Oncol , 13: 575-582, 1995
24. Sappino, A. P., Seelentag, W., Pelte, M. F., Alberto, P., and Vassalli, P. Tumor necrosis factor/cachectin and lymphotoxin gene expression in lymph nodes from lymphoma patients. Blood, 75: 958-962, 1990.
25. Ruco, L P., Pomponi, D., Pigott, R., Stoppacciaro, A., Monardo, F., Uccini, S., Boraschi, D., Tagliabue, A., Santoni, A , Dejana, E., Mantovani, A., and Baroni, C. D. Cytokine production (IL-1α, IL-1β, and TNF-α) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas: an immunocytochemical study Am J. Pathol., 137: 1163-1171, 1990
26. Ryffel, B., Brockhaus, M., Durmuller, U., and Gudat, F. Tumor necrosis factor receptors in lymphoid tissues and lymphomas: source and site of action of tumor necrosis factor α. Am. J Pathol., 139: 7-15, 1991
27. Gruss, H. J , and Dower, S. K. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood, 85: 3378-3404, 1995.
28. Sheibani, K., Winberg, C. D., Van De Velde, S., Blayney, D. W., and Rappaport, H. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. Am. J. Pathol., 127: 27-37, 1987.
29. Tsudo, M., Uchiyama, T , and Uchino, K. Expression of TAC antigen on activated normal human B cells. J Exp. Med., 160: 612-617, 1984.
30. Zubler, R. H , Lowenthal, J. W., Erard, F , Hashimoto, N., Devos, R., and Macdonald, R. Activated B cells express receptors for and proliferate in response to pure interleukin 2. J. Exp. Med , 160: 1170-1183, 1984.
31. Burdin, N , Péronne, C., Banchereau, J., and Rousset, F Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med., 177: 295-304, 1993.
32. Masood, R , Zhang, Y., Bond, M W., Scadden, D. T , Moudgil, T., Law, R. E., Kaplan, M. H., Jung, B , Espina, B. M., Lunardi-Iskandar, Y , Levine, A. M., and Gill, P. S. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood, 85: 3423-3430, 1995.
33. Benjamin, D., Knobloch, T , and Dayton, M A Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood, 80: 1289-1298, 1992.
34. Kishimoto, T. The biology of interleukin-6. Blood, 74: 1-10, 1989.
35. Jucker, M., Abts, H., Li, W., Schindler, R., Merz, H , Günther, A., Von Kalle, C., Schaadt, M , Diamantstein, T , Feller, A. C., Krueger, G. R. F , Diehl, V., Blankenstein, T., and Tesh, H. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood, 77: 2413-2418, 1991.
36. Agematsu, K., Takeuchi, S., Ichikawa, M , Yabuhara, A., Uehara, Y., Kawai, H., Miyagawa, Y., Ishii, K., Katsuyama, T., Nakahata, T., and Komiyama, A. Spontaneous production of interleukin-6 by Ki-1-positive large-cell anaplastic lymphoma with extensive bone destruction. Blood, 77. 2299-2301, 1991.
37. Takeshita, M., Sumiyoshi, Y., Masuda, Y., Ohshima, K., Yoshida, T., Kikuchi, M., and Muller, H Cytokine (interleukin-1α, interleukin-1β, tumor necrosis factor α, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma Pathol. Res. Pract., 189. 18-25, 1993.
38. Hsu, S M., Xie, S. S. and Waldron, J. A., Jr. Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas. Am. J. Pathol., 141: 915-923, 1992.
39. Shimizu, S., Hirano, T., Yoshioka, R., Sugai, S , Matsuda, T , Taga, T., Kishimoto, T., and Konda, S. Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). Blood, 72. 1826-1828, 1988.
40. Blay, J Y., Farcet, J. P., Lavaud, A , Radoux, D , and Chouaïb, S Serum concentrations of cytokines in patients with Hodgkin's disease Eur. J. Cancer, 30A: 321-324, 1994.
41. Salles, G., Bienvenu, J , Bastion, Y., Barbier, M., Doche, C., Dumontet, C., Barbier, Y., Felman, P., and Coiffier, B. Elevated circulating α TNF and soluble TNF-receptor levels are associated with adverse prognostic factors and poor outcome in lymphoma patients. Blood, 82: 136a, 1993.
42. 2), as B-cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor J Exp. Med., 165: 914-919, 1987.
43. Wanidworanum, C., and Strober, W. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol., 151. 6853-6861, 1993
44. de Waal Malefyt, R., Yssel, H., and de Vries, J E Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells J. Immunol., 150: 4754-4765, 1993
45. Blay, J. Y., Bertoglio, J , Fradelizi, D., and Chouaib, S. Involvement of TNF in LAK generation. Int. J. Cancer, 44: 598-604, 1989.
46. Steffen, M., Ottmann, O. G , and Moore, M. A. S Simultaneous production of tumor necrosis factor-α and lymphotoxin by normal T cells after induction with IL-2 and anti-T3 J Immunol., 140: 2621-2624, 1988.